Non-tuberculous mycobacterial disease in patients who were referred as MDR-TB in resource limited settings: need for more rapid identification

P. Tabarsi, P. Baghaei, P. Farnia, M. R. Masjedi, D. Mansouri (Tehran, Islamic Republic Of Iran)

Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Tabarsi, P. Baghaei, P. Farnia, M. R. Masjedi, D. Mansouri (Tehran, Islamic Republic Of Iran). Non-tuberculous mycobacterial disease in patients who were referred as MDR-TB in resource limited settings: need for more rapid identification. Eur Respir J 2008; 32: Suppl. 52, 2549

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Identification of potentially undiagnosed patients with nontuberculous mycobacterial lung disease using machine learning applied to primary care data in the UK
Source: Eur Respir J, 56 (4) 2000045; 10.1183/13993003.00045-2020
Year: 2020



Implementation of rapid drug-susceptibility testing for patients at high risk of multidrug-resistant tuberculosis in Cambodia
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013

IGRA testing to diagnose TB disease and infection. What is new in clinical practice and for programmatic management
Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination
Year: 2012


The MTBDRplus 2.0 for rapid diagnosis of multidrug-resistant tuberculosis among patients with high risk of TB resistance
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013

Beyond pulmonary nontuberculous mycobacteria disease: do extra-pulmonary forms represent an emerging clinical and public health threat?
Source: ERJ Open Res, 3 (3) 00091-2017; 10.1183/23120541.00091-2017
Year: 2017



HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015

Identification and management of non tuberculous mycobacteria in extra pulmonary cases in clinical practice
Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections
Year: 2009


Pulmonary diseases due to non-tuberculous mycobacteria in TB referral clinical center
Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Year: 2011

Active tuberculosis cases in migrants in Newham: should we extend screening criteria for latent tuberculosis infection
Source: International Congress 2017 – Migrants and screening
Year: 2017


TB "cross-border" - a new challenge in tuberculosis management
Source: Virtual Congress 2020 – Tuberculosis and society
Year: 2020


Identifying pulmonary tuberculosis in emergency rooms: a decision instrument for rapid patient isolation
Source: Annual Congress 2007 - Drug-resistant and multidrug-resistant tuberculosis
Year: 2007



A study of patients with pulmonary tuberculosis and confirmed coexistence of nontuberculous mycobacteria during treatment: Does the use of the additional acid-fast bacilli sputum test lead to shorter hospitalization?
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014


WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
Source: Eur Respir J 2011; 38: 516-528
Year: 2011



Frequency of rifampicin resistance in re-treatment cases of pulmonary tuberculosis using Gene-Xpert in a tertiary care hospital tuberculosis clinic
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015


Alternate diagnosis in clinically diagnosed pulmonary tuberculosis patients treated at tertiary care hospital in a high TB burden country
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020


Monitoring of drug resistance of TB mycobacteria in new pulmonary TB patients
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010

Treatment outcomes among multidrug-resistant tuberculosis (MDR-TB) cases at a referral hospital of infectious diseases in Italy
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016

Trilateral overlap of tuberculosis, diabetes and HIV-1 in a high-burden African setting: implications for TB control
Source: Eur Respir J, 50 (1) 1700004; 10.1183/13993003.00004-2017
Year: 2017